chr1-12001426-G-C

Variant names:

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 4P and 10B. PM1PP2PP3BP4BP6BS1BS2

The NM_014874.4(MFN2):c.842G>C(p.Cys281Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,613,878 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C281W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)

Exomes 𝑓: 0.00023 ( 2 hom. )

Consequence

MFN2
NM_014874.4 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:3

Conservation

PhyloP100: 9.60

Publications

4 publications found

Variant links:

Genes affected

MFN2 (HGNC:16877): (mitofusin 2) This gene encodes a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. This protein is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke. Two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]

MFN2 Gene-Disease associations (from GenCC):

neuropathy, hereditary motor and sensory, type 6A
Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;
Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
axonal hereditary motor and sensory neuropathy
Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
Charcot-Marie-Tooth disease type 2A2
Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
hereditary motor and sensory neuropathy type 6
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
multiple symmetric lipomatosis
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
severe early-onset axonal neuropathy due to MFN2 deficiency
Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

MFN2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PM1

In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 16 uncertain in NM_014874.4

PP2

Missense variant in the MFN2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 123 curated pathogenic missense variants (we use a threshold of 10). The gene has 23 curated benign missense variants. Gene score misZ: 1.6575 (below the threshold of 3.09). Trascript score misZ: 3.2174 (above the threshold of 3.09). GenCC associations: The gene is linked to Charcot-Marie-Tooth disease type 2A2, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;, severe early-onset axonal neuropathy due to MFN2 deficiency, hereditary motor and sensory neuropathy type 6, axonal hereditary motor and sensory neuropathy, multiple symmetric lipomatosis, neuropathy, hereditary motor and sensory, type 6A.

PP3

Multiple lines of computational evidence support a deleterious effect 7: BayesDel_addAF, BayesDel_noAF, phyloP100way_vertebrate, PrimateAI, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]

BP4

Computational evidence support a benign effect (MetaRNN=0.35620707).

BP6

Variant 1-12001426-G-C is Benign according to our data. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642. Variant chr1-12001426-G-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 214642.

BS1

Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000231 (337/1461530) while in subpopulation MID AF = 0.0042 (24/5714). AF 95% confidence interval is 0.0029. There are 2 homozygotes in GnomAdExome4. There are 200 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.

BS2

High Homozygotes in GnomAdExome4 at 2 AD,AR,SD gene

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MFN2	NM_014874.4 link	c.842G>C	p.Cys281Ser	missense_variant	Exon 9 of 19	ENST00000235329.10	NP_055689.1	O95140-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MFN2	ENST00000235329.10 link	c.842G>C	p.Cys281Ser	missense_variant	Exon 9 of 19	1	NM_014874.4	ENSP00000235329.5		O95140-1

Frequencies

GnomAD3 genomes

AF:

0.000138

AC:

AN:

152230

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000241

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00173

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00104

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.000132

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.000367

AC:

AN:

250444

AF XY:

0.000399

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.000116

Gnomad ASJ exome

AF:

0.00248

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.0000930

Gnomad NFE exome

AF:

0.000230

Gnomad OTH exome

AF:

0.000327

GnomAD4 exome

AF:

0.000231

AC:

337

AN:

1461530

Hom.:

Cov.:

AF XY:

0.000275

AC XY:

200

AN XY:

727056

show subpopulations

African (AFR)

AF:

0.0000597

AC:

AN:

33474

American (AMR)

AF:

0.000157

AC:

AN:

44674

Ashkenazi Jewish (ASJ)

AF:

0.00283

AC:

AN:

26136

East Asian (EAS)

AF:

0.00

AC:

AN:

39696

South Asian (SAS)

AF:

0.00113

AC:

AN:

86204

European-Finnish (FIN)

AF:

0.0000375

AC:

AN:

53378

Middle Eastern (MID)

AF:

0.00420

AC:

AN:

5714

European-Non Finnish (NFE)

AF:

0.0000863

AC:

AN:

1111888

Other (OTH)

AF:

0.000580

AC:

AN:

60366

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.475

Heterozygous variant carriers

122

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.000138

AC:

AN:

152348

Hom.:

Cov.:

AF XY:

0.000215

AC XY:

AN XY:

74504

show subpopulations

African (AFR)

AF:

0.0000240

AC:

AN:

41586

American (AMR)

AF:

0.00

AC:

AN:

15300

Ashkenazi Jewish (ASJ)

AF:

0.00173

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5190

South Asian (SAS)

AF:

0.00104

AC:

AN:

4826

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10618

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.000132

AC:

AN:

68034

Other (OTH)

AF:

0.00

AC:

AN:

2116

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.511

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000309

Hom.:

Bravo

AF:

0.000174

ESP6500AA

AF:

0.00

AC:

ESP6500EA

AF:

0.000116

AC:

ExAC

AF:

0.000313

AC:

Asia WGS

AF:

0.000577

AC:

AN:

3478

EpiCase

AF:

0.000491

EpiControl

AF:

0.000416

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:9Benign:3

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

not provided

Uncertain:4

Feb 21, 2025

GeneDx

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26257172, 32376792, 24863639, 39886061, 24126688) -

Apr 01, 2024

CeGaT Center for Human Genetics Tuebingen

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

MFN2: PP3, BP5 -

Jul 15, 2019

Mayo Clinic Laboratories, Mayo Clinic

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Nov 20, 2023

Revvity Omics, Revvity

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 2

Benign:2

Apr 27, 2017

Illumina Laboratory Services, Illumina

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease

Uncertain:1

Molecular Genetics Laboratory, London Health Sciences Centre

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Inborn genetic diseases

Uncertain:1

Jan 31, 2022

Ambry Genetics

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The p.C281S variant (also known as c.842G>C), located in coding exon 7 of the MFN2 gene, results from a G to C substitution at nucleotide position 842. The cysteine at codon 281 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant Charcot-Marie-Tooth disease (CMT) type 2A2A and hereditary motor and sensory neuropathy VIA; however, its contribution to the development of autosomal recessive Charcot-Marie-Tooth disease (CMT) type 2A2B is uncertain. -

Optic atrophy

Uncertain:1

Jan 01, 2020

Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;

Uncertain:1

Jan 23, 2020

Baylor Genetics

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Hereditary motor and sensory neuropathy with optic atrophy

Uncertain:1

Apr 27, 2017

Illumina Laboratory Services, Illumina

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified

Benign:1

Dec 19, 2016

Athena Diagnostics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Uncertain

0.39

BayesDel_addAF

Pathogenic

0.23

BayesDel_noAF

Pathogenic

0.50

CADD

Uncertain

(source)

DANN

Uncertain

0.99

DEOGEN2

Uncertain

0.69

D;D

Eigen

Uncertain

0.30

Eigen_PC

Uncertain

0.42

FATHMM_MKL

Pathogenic

0.99

LIST_S2

Uncertain

0.97

D;.

M_CAP

Uncertain

0.15

MetaRNN

Benign

0.36

T;T

MetaSVM

Uncertain

0.78

MutationAssessor

Uncertain

2.0

M;M

PhyloP100

9.6

PrimateAI

Pathogenic

0.87

PROVEAN

Pathogenic

-4.6

D;D

REVEL

Pathogenic

0.82

Sift

Uncertain

0.017

D;D

Sift4G

Benign

0.18

T;T

Polyphen

0.22

B;B

Vest4

0.84

MutPred

0.70

Gain of disorder (P = 3e-04);Gain of disorder (P = 3e-04);

MVP

0.98

MPC

1.2

ClinPred

0.15

GERP RS

5.2

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.1

Varity_R

0.76

gMVP

0.94

Mutation Taster

=27/73

disease causing

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over